The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis - Raggi, P.; Chertow, G. M.; Torres, P. U.; Csiky, B.; Naso, A.; Nossuli, K.; Moustafa, M.; Goodman, W. G.; Lopez, N.; Downey, G.; Dehmel, B.; Floege, J. (Nephrology, dialysis, transplantation, 2011)
Keywords: Adult; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Aorta; Aortic valve; Biological and medical sciences; Calcification; Calcification (ectopic); Calcinosis - drug therapy; Calcinosis - etiology; Calcitriol; Calcium; Cinacalcet Hydrochloride; Clinical trials; Computed tomography; coronary artery; Coronary Artery Disease - drug therapy; Coronary Artery Disease - etiology; Dose-Response Relationship, Drug; Emergency and intensive care: renal failure. Dialysis management; Female; Follow-Up Studies; General and cellular metabolism. Vitamins; Heart; Hemodialysis; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary - drug therapy; Hyperparathyroidism, Secondary - etiology; Intensive care medicine; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - therapy; Male; Medical sciences; Middle Aged; Mitral valve; Naphthalenes - therapeutic use; Parathyroid hormone; Pharmacology. Drug treatments; Phosphate; Prognosis; Prospective Studies; Renal Dialysis; Sterols; Vitamin D; Vitamin D - therapeutic use; Vitamins - therapeutic use; Endocrinopathy; Kidney disease; Human; Urinary system disease; secondary hyperparathyroidism; Calcimimetic agent; Hemodialysis; Low dose; Peptide hormone; Antihormone; Extrarenal dialysis; Vitamin D; Parathyroid hormone; Parathyroid diseases; Renal failure; Calcification; Cinacalcet; Hyperparathyroidism